glutathione and pulmonary hypertension Pathophysiology of Group 3 Associated with Lung Diseases and/or Hypoxia Immunotherapy of Endothelin-1 Receptor Type
Immunotherapy of Endothelin 1 Receptor Type A for Pulmonary Arterial Hypertension JACC Epidemiology and treatment of pulmonary arterial hypertension Nature Reviews Cardiology Strategizing Drug Therapies in Pulmonary Hypertension for Improved Outcomes A new perspective on targeting pulmonary arterial hypertension: Programmed cell death pathways (Autophagy, Pyroptosis, Ferroptosis) ScienceDirect
Pay in 4 interest-free payments of $6.35 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11



